Subscribe now

A drug that stops cancer treatments damaging ovaries could preserve patients’
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). “If they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,” says Geraldine Hartshorne of the University of Warwick.

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop